Figure 9.
Line graph showing the effect of CGRP transgene on neurological scores.
Notes: The Tat-GS NP-pLXSN-CGRP-treated group had significantly improved neurological scores compared with the SAH and Tat-GS NP-pLXSN-treated groups. ***P < 0.001 versus Tat-GS NP-pLXSN-CGRP-treated groups.
Abbreviations: NPs, nanoparticles; SAH, subarachnoid hemorrhage; Tat-GS, Tat peptide-decorated gelatin-siloxane nanoparticles.